Montanide adjuvant

BIOLOGICAL2 trials

Sponsors

Centre Hospitalier Universitaire Vaudois, National Heart, Lung, and Blood Institute (NHLBI)

Conditions

Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)MelanomaMyelodysplastic Syndrome (MDS)

Phase 1

Immunotherapy of Melanoma Patients

CompletedNCT00112216

Centre Hospitalier Universitaire VaudoisMelanoma

Start: 1999-05-31End: 2007-06-30Updated: 2013-04-24

Phase 2

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

CompletedNCT00488592

National Heart, Lung, and Blood Institute (NHLBI)Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Myelodysplastic Syndrome (MDS)

Start: 2007-06-30End: 2010-04-30Updated: 2021-07-12